Epstein Secrets

BMGF in October 2007 and bgC3 in April 2010. Dr. Nikolic has led select for-profit and not-for-profit investment activities at the aforementioned Gates-affiliated organizations. On the for-profit side, Dr. Nikolic has led investments in various life- science/IT/healthcare companies such as Foundation

the Principals' previous experience in investing and monitoring the industry, as well as their strong connections globally. Where appropriate, the Principals will provide advice and introductions to the Fund's portfolio companies. The Principals will typically take a board-observer seat and/or ask for reg

Biosys Capital Partners, LP October_, 2014 Gates Ventures, LLC 2365 Carillon Point Kirkland, WA

l or exceed $250,000 for such fiscal year. 48093278_2 EFTA_R1_02161164 EFTA02717285 15. General Partner hereby represents and warrants that the Principals will beneficially own (directly or indirectly through one or more entities), in the aggregate, no less than 75% of the economic interests in the Ge

Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities. On the for-profit side, Boris led investments

and well executed due diligence of critical risks is key to investment success. We believe that the complementary skillsets and backgrounds of the Principals will allow for the identification of critical issues and risks. We work closely with our network of founders, scientists & academicians, pharmaceut